{
    "clinical_study": {
        "@rank": "55256", 
        "arm_group": {
            "arm_group_label": "18F-FDG PET-CT", 
            "description": "A total of 10 patients with acute respiratory distress syndrome (ARDS) will be imaged with 2-18F-fluoro-2-deoxy-D-glucose (18F-FDG) and PET-CT scan."
        }, 
        "biospec_descr": {
            "textblock": "Blood samples will be drawn and plasma stored for future potential biomarker studies."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The goal of this study is to investigate acute respiratory distress syndrome (ARDS) with\n      positron emission tomography (PET) imaging and to examine the distribution of inflammation,\n      as measured by neutrophil metabolic activity."
        }, 
        "brief_title": "Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Respiratory Failure", 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Pneumonia", 
                "Respiratory Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Mechanically ventilated patients scheduled to undergo a CT scanning for their routine\n             clinical care\n\n          -  More than 24 hours of mechanical ventilation\n\n          -  Less than 15 days of mechanical ventilation if patient presents ALI/ARDS (in order to\n             exclude the late, fibrotic, stage of ARDS).\n\n        Exclusion Criteria:\n\n          -  Age less than 18 years\n\n          -  Hemodynamic instability, defined as: systolic blood pressure (SBP) < 90mmHg without\n             the use of vasopressors or inotropic agents. We will exclude from the study patients\n             on vasopressors, with the exception of: dopamine up to a dose of 3 mcg/kg/min, or\n             norepinephrine up to 4 mcg/min, or neosynephrine up to 40 mcg/min\n\n          -  Hypoxemia, defined as: PaO2 < 70 mmHg on an inspired oxygen fraction (FiO2) greater\n             than or equal to 0.9; FiO2 greater than or equal to 0.8 at baseline\n\n          -  Patients requiring more than one vasopressor\n\n          -  Hemodynamic and/or respiratory instability (as defined, respectively, in 2 and 3),\n             that develop when the patient is mobilized during routine nursing care\n\n          -  Any acute or chronic condition which, in the opinion of the investigator, might\n             confound the imaging measurements (such as, but not limited to, severe bronchospasm,\n             pulmonary infection, and lung tumor)\n\n          -  \"Air leaks\" requiring tube thoracostomy (e.g., pneumothorax, bronchopleural fistula)\n\n          -  Pregnancy (since this is a study which would expose a fetus to radiation risk)\n\n          -  Patients who have neither an arterial nor a central venous line at the time of the\n             enrollement"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult intensive care patients requiring mechanical ventilation who have been on the\n        ventilator for more than 24 hours."
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01806532", 
            "org_study_id": "2008P000561"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "computed tomography and positron emission tomography", 
            "respiration, artificial", 
            "respiratory distress syndrome, adult"
        ], 
        "lastchanged_date": "March 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Massachusetts General Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Each patient will undergo PET-CT scans and the regional 2-18F-fluoro-2-deoxy-D-glucose (18F-FDG) activity will be measured.  This is a measure of regional neutrophil metabolic activity and is used to assess inflammation in the lung. The degree of inflammation will be related to the regional expansion of the lung, as measured by CT scan.", 
            "measure": "Regional 18F-FDG activity", 
            "safety_issue": "No", 
            "time_frame": "Day of imaging."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01806532"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Marcos Vidal Melo", 
            "investigator_title": "Associate Professor, Harvard University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}